According to Nova one advisor, the global Controlled Release Drug Delivery market size is expected to hit around USD 111.14 billion by 2030 from valued at USD 47.39 billion in 2021 and growing at a CAGR of 11.5% from 2022 to 2030.
According to Nova one advisor, the global Controlled Release Drug Delivery market size is expected to hit around USD 111.14 billion by 2030 from valued at USD 47.39 billion in 2021 and growing at a CAGR of 11.5% from 2022 to 2030.
Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/7141
The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.
The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.
The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.
Report Scope of the Controlled Release Drug Delivery Market
| Report Coverage | Details |
| Market Size | USD 111.14 Billion by 2030 |
| Growth Rate | CAGR of 11.5% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Technology, release mechanism, application and Region, |
| Companies Mentioned | Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; Capsugel |
Key Takeaways:
- By Application, the India Controlled Release Drug Delivery market was valued at USD 1.9 Billion in 2021 and expected to witness growth at a CAGR of 14.9% from 2022 to 2030.
- Based on application, oral controlled release systems held the largest share in the market in 2021 owing to increasing usage and ease of convenience offered for the administration of medication
- Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety
- The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/7141
Regional Insights
In 2021, North America was the leading regional market in the global arena with over 43.8% market share. Supportive government initiatives taken for the development of controlled release drug delivery and growing investments in R&D are expected to propel the market growth in the region. Besides this, the presence of prominent market players in promoting the adoption of controlled release drug delivery systems. The increasing burden of chronic diseases such as cancer, diabetes, and cardiac disorders is aiding the market growth. Spiraling utilization of controlled release drug delivery systems for the treatment of hypertension is one of the key trends escalating the growth of the regional market.
Europe accounted for the second-largest share in 2019 owing to increasing research and developmental activities and the presence of major pharmaceutical companies in the region. With the significant rise in patients suffering from chronic diseases such as cancer, diabetes, and COPD, the regional market is poised to tread along a healthy growth track over the coming years. Asia Pacific is likely to witness the highest CAGR during the forecast period. The region has been gaining global attention due to increasing development in the pharmaceutical industry. Rapid expansion in the Indian and Chinese pharmaceutical industries is positively affecting the market in the region. The presence of a large geriatric population in Japan is another major factor triggering product adoption.
Some of the prominent players in the Controlled Release Drug Delivery Market include:
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc.
- Aradigm Corporation
- Capsugel
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Controlled Release Drug Delivery market
- Technology
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others (Microelectromechanical Technology, Liposomes)
- Release Mechanism
- Polymer Based Systems
- Micro Reservoir Partition Controlled Drug Delivery Systems
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Osmotic Pressure Activated
- Hydrodynamic Pressure Activated
- Vapor Pressure Activated
- Mechanically Activated
- Magnetically Activated
- Chemically Activated
- pH Activated
- Hydrolysis Activated
- Enzyme Activated
- Application
- Metered Dose Inhalers
- Injectable
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-drug delivery Systems
- Drug Eluting Stents
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7141
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
Blog: https://qyresearchmedical.com/